proline has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HJ; Chen, ZZ; Wu, SQ; Xiong, DL; Xu, ZS; Zhan, R; Zhang, JS; Zhang, JY | 1 |
Bosanquet, AG; Daniel, PT; Dörken, B; Hummel, M; Sturm, I | 1 |
2 other study(ies) available for proline and Leukemia, Lymphocytic, Chronic, B-Cell
Article | Year |
---|---|
Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
Topics: Aged; Apoptosis; B-Lymphocytes; Chromosome Deletion; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 13; DNA, Neoplasm; Female; Frameshift Mutation; Gene Expression Regulation, Leukemic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Proteins; NF-kappa B; Oligopeptides; Proline; Protein Structure, Tertiary; Receptor, Notch1; RNA, Messenger; RNA, Neoplasm; Thiocarbamates; Transcription Factor RelA; Transcription Factor RelB; Trisomy | 2015 |
In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.
Topics: Aged; Antineoplastic Agents; Apoptosis; Arginine; Chlorambucil; Codon; Cyclophosphamide; DNA Mutational Analysis; Doxorubicin; Drug Resistance, Neoplasm; Female; Gamma Rays; Gene Expression Regulation, Neoplastic; Genes, p53; Homozygote; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Polymorphism, Single-Stranded Conformational; Prognosis; Proline; Vidarabine Phosphate; Vincristine | 2005 |